Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
    • Awards
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Krystal Biotech Inc.

346.58
+9.562.84%
Volume:407.81K
Turnover:140.84M
Market Cap:10.26B
PE:43.51
High:348.03
Open:337.44
Low:335.72
Close:337.02
52wk High:382.54
52wk Low:136.73
Shares:29.60M
Float Shares:23.54M
Volume Ratio:2.19
T/O Rate:1.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.97
EPS(LYR):6.84
ROE:20.12%
ROA:9.37%
PB:7.55
PE(LYR):50.67

Loading ...

OverviewCompanyNewsFilings

Bank of America Securities Remains a Buy on Krystal Biotech (KRYS)

TIPRANKS
·
Mar 24

Krystal Biotech Inc : Bofa Global Research Raises Price Objective to $325 From $318

THOMSON REUTERS
·
Mar 24

U.S. RESEARCH ROUNDUP-Apogee Therapeutics, Insmed, Sunoco

Reuters
·
Mar 24

Palvella Therapeutics appoints Jennifer J. McDonough as SVP of Market Access and Patient Services

Reuters
·
Mar 23

The Bull Case For Krystal Biotech (KRYS) Could Change Following Q4 Beat And CEO Stock Sales

Simply Wall St.
·
Mar 10

Krystal Biotech Files Initial Beneficial Ownership Statement for EVP, Head of International Laurent Louis Jean Goux

Reuters
·
Mar 07

Krystal Biotech Files Initial Beneficial Ownership Statement for EVP, General Counsel John Charles Thomas

Reuters
·
Mar 07

Krystal Biotech President, R&D Suma Krishnan Disposes of Common Shares

Reuters
·
Mar 07

Krystal Biotech Director Daniel Janney Disposes of Common Shares

Reuters
·
Mar 04

Krystal Biotech Director Daniel Janney Disposes of Common Shares

Reuters
·
Feb 27

Krystal Biotech RMAT Win Shifts Focus To Broader Gene Therapy Pipeline

Simply Wall St.
·
Feb 25

Analyst Rate

Buy
Buy
92.31%
Hold
7.69%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 03, 2026 Pre-MKt
Financial Report Announcement
May 04, 2026 Pre-MKt
Financial Report Announcement
Feb 17, 2026 Pre-MKt
Financial Report Announcement
Jan 11, 2026 Pre-MKt
Financial Report Announcement
Nov 03, 2025 Pre-MKt

Dividend History

no data

No relevant data is available

Valuation Analysis

43.51
Current
25.91
Sector Average
73.26%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
43.51
Maximum
469.35
+1 STD
122.73
Minimum
-121.64
-1 STD
-70.92
Average
25.91

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.